-
DOI: 10.1099/00222615-43-2-156
Abed Y, Bollet C, De Micco P
(1995).
Demonstration of Mycobacterium kansasii species heterogeneity by the amplification of the 16S-23S spacer region.
-
DOI: 10.1128/jcm.35.3.596-599.1997
Iinuma Y, Ichiyama S, Hasegawa Y, Shimokata K, Kawahara S, Matsushima T
(1997).
Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing.
-
DOI: 10.1007/s10495-012-0792-4
Lim YJ, Choi HH, Choi JA, Jeong JA, Cho SN, Lee JH, Park JB, Kim HJ, Song CH
(2013).
Mycobacterium kansasii-induced death of murine macrophages involves endoplasmic reticulum stress responses mediated by reactive oxygen species generation or calpain activation.
-
DOI: 10.1093/gbe/evv035
Wang J, McIntosh F, Radomski N, Dewar K, Simeone R, Enninga J, Brosch R, Rocha EP, Veyrier FJ, Behr MA
(2015).
Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.
-
DOI: 10.1371/journal.pone.0122804
Nataraj V, Pang PC, Haslam SM, Veerapen N, Minnikin DE, Dell A, Besra GS, Bhatt A
(2015).
MKAN27435 is required for the biosynthesis of higher subclasses of lipooligosaccharides in Mycobacterium kansasii.
-
DOI: 10.3389/fmicb.2016.00795
Gcebe N, Michel A, Gey van Pittius NC, Rutten V
(2016).
Comparative Genomics and Proteomic Analysis of Four Non-tuberculous Mycobacterium Species and Mycobacterium tuberculosis Complex: Occurrence of Shared Immunogenic Proteins.
-
DOI: 10.1038/s41598-018-21562-z
Bakula Z, Brzostek A, Borowka P, Zaczek A, Szulc-Kielbik I, Podpora A, Parniewski P, Strapagiel D, Dziadek J, Proboszcz M, Bielecki J, van Ingen J, Jagielski T
(2018).
Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis.
-
DOI: 10.3389/fmicb.2021.718477
Mussi VO, Simao TLBV, Almeida FM, Machado E, de Carvalho LD, Calixto SD, Sales GAM, Carvalho ECQ, Vasconcellos SEG, Catanho M, Suffys PN, Lasunskaia EB
(2021).
A Murine Model of Mycobacterium kansasii Infection Reproducing Necrotic Lung Pathology Reveals Considerable Heterogeneity in Virulence of Clinical Isolates.
-
DOI: 10.1016/j.jgar.2021.12.010
Srivastava S, Pasipanodya JG, Heysell SK, Boorgula GD, Gumbo T, McShane PJ, Philley JV
(2021).
An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease.
-
DOI: 10.1128/aac.00687-22
Singh S, Gumbo T, Boorgula GD, Shankar P, Heysell SK, Srivastava S
(2022).
Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease.
-
DOI: 10.1128/spectrum.00819-24
Kim H, Shin SJ
(2024).
Immunogenicity and vaccine potential of clinical isolate Mycobacterium kansasii strain against Mycobacterium tuberculosis infection.
-
DOI: 10.1099/ijs.0.025478-0
Saito H, Iwamoto T, Ohkusu K, Otsuka Y, Akiyama Y, Sato S, Taguchi O, Sueyasu Y, Kawabe Y, Fujimoto H, Ezaki T, Butler R
(2010).
Mycobacterium shinjukuense sp. nov., a slowly growing, non-chromogenic species isolated from human clinical specimens.